Nurix Therapeutics

NRIXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.664 B

$25.67 +1.02%

Close of 22 Sept 2026

Revenue

$84.0M

#2564 by revenue

Earnings

-$264.5M

Loss-making

Shares outstanding

103,781,683

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#81PrecigenPGEN$2.82B
#82NewAmsterdam PharmaNAMS$2.79B
#83Nurix TherapeuticsNRIX$2.66B
#84Structure TherapeuticsGPCR$2.63B
#85Disc MedicineIRON$2.63B

What if Nurix Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$291,322.79

Per share 11,349× higher

Bitcoin $1.74T

$16,781.91

Per share 654× higher

Nvidia $5.52T

$53,147.79

Per share 2,070× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Nurix Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.